Skip to main content
Health & Medicine

Optogenetic Therapy for Restoring Aspects of Visual Function.

| Source: The New England journal of medicine

Retinitis pigmentosa is an inherited degenerative retinal disease that can lead to irreversible blindness. Optogenetic therapy has shown potential for restoring visual function at late stages of the disease. In this open-label study, we evaluated the safety of ganglion cell-directed optogenetic therapy in 10 participants with blindness due to advanced retinitis pigmentosa. Each participant received a single intravitreal injection of an adeno-associated viral (AAV) vector encoding the red-shifted

Retinitis pigmentosa is an inherited degenerative retinal disease that can lead to irreversible blindness. Optogenetic therapy has shown potential for restoring visual function at late stages of the disease. In this open-label study, we evaluated the safety of ganglion cell-directed optogenetic therapy in 10 participants with blindness due to advanced retinitis pigmentosa. Each participant received a single intravitreal injection of an adeno-associated viral (AAV) vector encoding the red-shifted channelrhodopsin ChrimsonR in the worse-seeing eye. The primary outcome was safety. Secondary outcomes included changes in light sensitivity as measured by full-field stimulus threshold (FST) testing conducted with the untreated eye patched and with the use of light-stimulating goggles designed to activate ChrimsonR. The definition of a clinically meaningful improvement in the FST (based on evidence from the literature and not prespecified in the protocol) was a decrease of at least 0.6 log units (i.e., an increase in light sensitivity by a factor of approximately 4). A total of 34 ocular adverse events occurred among 9 of the 10 participants, including 23 mild events and 10 moderate events. One severe event occurred: transient occlusion of the central retinal artery that occurred immediately after intravitreal injection and resolved within minutes after instillation of iopidine. Light sensitivity increased in 7 of the 10 participants, with increases ranging from a factor of 2.0 to a factor of 62.3; 6 participants had a clinically meaningful increase in light sensitivity. Within the limits of this small study, intravitreal administration of a ChrimsonR-expressing AAV vector targeting retinal ganglion cells combined with use of light-stimulating goggles was safe. Additional research is needed to further assess safety and efficacy. (Funded by GenSight Biologics; PIONEER ClinicalTrials.gov number, NCT03326336.).

Read the original source →

Related Stories

Health & Medicine

Distinct nanoscale architectures of GABAergic inhibitory synapses predict diverse synaptic output.

GABAergic synaptic inhibition is heterogenous across neuronal compartments, and plays a critical role in shaping local, cellular, and circuit excitability. In pyramidal neurons, inhibition is mediated by GABA A receptors (GABA A Rs) clustered at the inhibitory postsynaptic domain (iPSD). Synaptic strength depends not only on the number of GABA A Rs within the iPSD, but also on their precise nanoscale organization into discrete subsynaptic domains (SSDs). These SSDs often align with presynaptic G

Continue reading
Health & Medicine

Leptin Receptor + cells create a perisinusoidal niche for thrombopoiesis in the bone marrow by synthesizing CXCL14.

Leptin Receptor-expressing (LepR + ) stromal cells in the bone marrow are a critical source of growth factors for the maintenance of hematopoietic stem cells (HSCs) and most restricted hematopoietic progenitors. An important unresolved question is whether they also regulate terminal differentiation in some hematopoietic cells. We found that bone marrow LepR + cells promote thrombopoiesis by synthesizing the chemokine CXCL14. Cxcl14 -expressing LepR + cells extend fine processes that wrap around

Continue reading
Health & Medicine

SCN1B intron 3 retention results in a nonsense-mediated decay-sensitive mRNA linked to developmental and epileptic encephalopathy.

Biallelic variants in the voltage-gated sodium channel (VGSC) gene SCN1B are linked to developmental and epileptic encephalopathy type 52 (DEE52). SCN1B encodes two isoforms: transmembrane β1, generated by all 6 coding exons, and β1B, generated by exons 1 to 3 followed by retention of intron 3 ( SCN1B -IR). Transmembrane β1 subunits are multifunctional proteins that regulate sodium current and channel cell-surface expression, participate in cell-cell and cell-matrix adhesion, a

Continue reading
Health & Medicine

Anomeric configuration encodes mesophase preference of glucosylceramides in phospholipid membranes.

Glycosphingolipids are key components of the cell glycocalyx, yet the extent to which their anomeric configuration affects their membrane organization remains unclear. Glucosylceramide (GlcCer) exists as α- and β-anomers with distinct biological activities, while the biophysical basis for these differences is unknown. Here, using nitroxide spin-labeled analogs of α- and β-GlcCer, we examined how the glycosidic stereochemistry affects their partitioning in phospholipid bil

Continue reading
Health & Medicine

A genome-wide senescence synthetic lethality screen identifies PARP16 as a senolytic target.

Accumulation of senescent cells is increasingly viewed as a significant contributor to aging and age-related diseases. To date, the elimination of senescent cells through small molecule senolytic agents has largely relied on a limited number of repurposed agents, often leveraged from previous oncological applications. Here, we describe a CRISPR-based, genome-wide, synthetic lethal screen for senescent cells. From this screen, we identify a number of genes whose deletion appears to be well tolera

Continue reading